Jenna Leigh Wojkowski is a pharmacist who is specialized in Oncology in Cleveland, Ohio. Patients can reach her at 11100 Euclid Ave, Cleveland or contact her on 216-844-0444. Active license number of Jenna Leigh Wojkowski is 03442165 for Oncology in Ohio. Jenna Leigh Wojkowski is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Jenna Leigh Wojkowski speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jenna Leigh Wojkowski
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
11100 Euclid Ave, Cleveland, Ohio, 44106-1716
Phone:
216-844-0444
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jenna Leigh Wojkowski are as mentioned below.
NPI Number:
1417652413
NPI Enumeration Date:
31 Mar, 2023
NPI Last Update On:
31 Mar, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jenna Leigh Wojkowski are as mentioned below.
Specialization
License Number
State
Status
Oncology
03442165
Ohio
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2410 Scranton Rd Apt 416, Cleveland, Ohio
Zip:
44113-4326
Phone Number:
440-567-3402
Fax Number:
--
Patients can reach Jenna Leigh Wojkowski at 11100 Euclid Ave, Cleveland, Ohio or can call on phone at 216-844-0444.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.